1. Introduction {#sec1-jof-03-00009}
===============

*Xanthophyllomyces dendrorhous* (with *Phaffia rhodozyma* as its anamorphic state) is a basidiomycetous red yeast that accumulates astaxanthin \[[@B1-jof-03-00009]\], which is a unique feature among fungi \[[@B2-jof-03-00009]\]. This carotenoid is formed via the mevalonate pathway starting with a condensation of two molecules of geranylgeranyl pyrophosphate, a 4-step desaturation, cyclization and a final 4-ketolation plus 3-hydroxylation \[[@B3-jof-03-00009],[@B4-jof-03-00009]\]. In contrast to other organisms, only three genes are involved in the whole pathway from phytoene to astaxanthin, which facilitates genetic modification of carotenoid biosynthesis in *X. dendrorhous.* This yeast has the potential to be engineered as a cell-factory for the production of industrially valuable carotenoids \[[@B5-jof-03-00009]\]. Tools and techniques for genetic manipulations of *X. dendrorhous* are available \[[@B6-jof-03-00009]\], including several integrative transformation plasmids based on four different selection markers \[[@B7-jof-03-00009],[@B8-jof-03-00009]\]. It is also advantageous for the development of high-yield carotenoid producers since a carotenoid pathway that can be manipulated is already established, a carotenoid storage system exists and a very active acetyl-CoA metabolism can be utilized. The published genomic sequence of *X. dendrorhous* CBS6938 \[[@B9-jof-03-00009]\] is also very helpful for genetic engineering of the carotenoid pathway.

The potential of *X. dendrorhous* for the production of economically interesting carotenoids like astaxanthin for feed and zeaxanthin as a nutraceutical for eye care has been demonstrated. The highest production of astaxanthin was reached by combining classical mutagenesis with genetic pathway engineering \[[@B7-jof-03-00009]\]. Starting from a high-yield astaxanthin mutant, genes of three limiting enzymes were over-expressed, enhancing metabolite flow toward carotenoid biosynthesis and into the astaxanthin pathway \[[@B7-jof-03-00009]\].

Zeaxanthin is another carotenoid of interest as a nutraceutical, which is important for protection of our vision. For the engineering of a zeaxanthin producing strain, a mutant with inactive astaxanthin synthase accumulating β-carotene \[[@B10-jof-03-00009],[@B11-jof-03-00009]\] was used to extend the carotenoid pathway to zeaxanthin by expression of a bacterial β-carotene hydroxylase gene and engineering of an enhanced metabolite flow into the carotenoid pathway \[[@B12-jof-03-00009]\].

Hydroxylated carotenoids such as the dihydroxy compound zeaxanthin \[[@B13-jof-03-00009]\], tetrahydroxy-β-carotene derivative nostoxanthin \[[@B14-jof-03-00009]\] and various other hydroxylated acyclic carotenoids \[[@B15-jof-03-00009]\] have been generated in *Escherichia coli* by combination of carotenogenic genes from different organisms. It has been shown that not only zeaxanthin but also several other hydroxyl derivatives have superior antioxidative activity. In our engineering approach with *X. dendrorhous*, we utilized β-carotene mutants to integrate hydroxylase and ketolase genes from bacteria and algae and finally chemically reduced the resulting tetrahydroxy-monoketo and tetrahydroxy-diketo products to a pentahydroxy and a hexahydroxy β-carotene derivative, respectively.

2. Materials and Methods {#sec2-jof-03-00009}
========================

2.1. Strains and Cultivation {#sec2dot1-jof-03-00009}
----------------------------

The β-carotene accumulation mutant of *X. dendrorhous* strain PR1-104 was generated by ethyl-methane sulphonate mutagenesis and selection for carotenoid content \[[@B10-jof-03-00009]\]. This mutant and transformants were grown as shaking cultures (50 mL in 500 mL baffled Erlenmeyer flasks, 180 rpm) over 7 days in YM medium (0.3% yeast extract, 0.3% malt extract, 0.5% peptone, 1.0% glucose) with white light illumination. For selection of transformants on agar plates, geneticin (G418 sulfate, 100 µg/mL), hygromycin (60 µg/mL) or nourseothricin (30 µg/mL) were added. *Escherichia coli* strains DH5α and JM110 used for genetic manipulations and generation of carotenoid standards were grown in LB medium containing ampicillin (100 µg/mL) and chloramphenicol (34 µg/mL) according to the plasmids involved.

2.2. Plasmid Construction and Transformantion of X. dendrorhous, Combinatorial Biosynthesis of Carotenoid Standards in E. coli {#sec2dot2-jof-03-00009}
------------------------------------------------------------------------------------------------------------------------------

The integrative plasmids pPR2TNo-crtZo \[[@B12-jof-03-00009]\] and pPRcDNA1bkt830 \[[@B11-jof-03-00009]\] were previously described. Details on the origin of genes and the primers for the amplification of the *X. dendrorhous* transformation plasmids are shown in [Table 1](#jof-03-00009-t001){ref-type="table"}. For the construction of plasmid pPR2TNH-crtG, the *crtG* gene from plasmid pUC-Bre-O11 \[[@B16-jof-03-00009]\] was amplified, which also generated an *Eco*RI and *Xho*I restriction site ([Table 1](#jof-03-00009-t001){ref-type="table"}), and was cloned into the *Xcm*I site of the *E. coli* plasmid pMon38201 by its a-overhang \[[@B17-jof-03-00009]\]. From there, the *crtG* gene was cut out with *Eco*RI and *Xho*I and ligated into pUC8ΔEcoRI-HNNH \[[@B7-jof-03-00009]\] for fusion with the promoter and terminator of the glyceraldehyde phosphate dehydrogenase gene from *X. dendrorhous*. Then, the whole cassette was cut out by restriction with *Hin*dIII and ligated into the *Hin*dIII site of pPR2TNH \[[@B7-jof-03-00009]\], yielding pPR2TNH-crtG. Transformation of *X. dendrorhous* was performed by electroporation as described in Visser et al. \[[@B6-jof-03-00009]\] with 10 μg plasmid DNA. After phenol-chloroform purification, plasmid DNA was linearized by digestion with *Sfi*I.

Carotenoid standards were generated in *E. coli* by combinatorial transformation of plasmids pACCAR25ΔcrtX \[[@B18-jof-03-00009]\] plus pUC-Bre-O11 \[[@B16-jof-03-00009]\] for nostoxanthin, caloxanthin and zeaxanthin, pACCAR25ΔcrtX \[[@B18-jof-03-00009]\] plus pCRBKT \[[@B19-jof-03-00009]\] for canthaxanthin, echinenone and β-carotene and pACCAR25ΔcrtX plus pPEU30crtO \[[@B20-jof-03-00009]\] for the synthesis of 4-keto-zeaxanthin.

2.3. Carotenoid Extraction, Purification and Chemical Derivatization {#sec2dot3-jof-03-00009}
--------------------------------------------------------------------

For carotenoid extraction, 20 mg of freeze-dried *X. dendrorhous* cells were mixed with 500 µL glass beads (0.25--0.5 mm), 675 µL methanol and 75 µL of a 60% KOH solution for saponification and broken in a cell mill (Retsch MM 400) for 8 min at a frequency of 30 per second and heated for 20 min at 60 °C. Samples containing keto carotenoid were extracted without addition of KOH. After partitioning of the carotenoid extract into 50% diethyl ether in petrol (bp 40--60 °C), the upper phase was collected and dried in a stream of nitrogen. Carotenoids were quantified from three independently grown cultures.

For the purification of multi-hydroxy keto carotenoids, the extract of PR1-104-ZGbkt was fractionated by TLC on activated silica plates developed with toluene/ethyl acetate/methanol (65:35:5, by volume). The bands with an *R~f~* value of 0.20 and 0.25 were collected and extracted with acetone.

The reduction of carotenoid ketones dissolved in ethanol to the corresponding alcohol was performed according to Eugster \[[@B22-jof-03-00009]\] with NaBH~4~. The reaction mixture was transferred to 65% diethyl ether in petrol (bp 40--60 °C) and the upper phase collected and dried in stream of nitrogen. The same procedure was applied to canthaxanthin, yielding 4,4'-diketo-β-carotene together with 4-HO-4'-keto-β-carotene and to echinenone yielding 4-HO-β-carotene.

2.4. HPLC and HR-ESI-MS Analysis {#sec2dot4-jof-03-00009}
--------------------------------

HPLC analysis was performed on three different HPLC systems. For separation of the non-ketolated multi-hydroxy carotenoids, system I with a 15 × 0.4 cm Nucleosil 100 C18, 3 µm column and acetonitrile (ACN)/methanol/2-propanol (85:10:5, by volume) plus 3% H~2~O \[[@B23-jof-03-00009]\] was used as mobile phase with a flow rate of 0.8 mL/min at 10 °C. System II was employed for the separation of the hydroxy-keto carotenoids and their reduction products on a 25 cm C30 RP, 3 µm column (YMC, Wilmington, NC, USA) with a mobile phase of 3% methyl tertiary-butyl ether in methanol for 48 min followed by an increase to 20% with a flow rate of 0.8 mL/min at 20 °C. This system was also used for the quantification of the keto derivatives. HR-ESI-MS analysis was carried out in system III on a 2.1 mm × 50 mm ACQUITY UPLC BEH C18, 1.7 µm column. A binary gradient was applied with ACN (+0.1% formic acid) and H~2~O (+0.1% formic acid) for 12 min in the following steps: 0--2 min 5% ACN , 2--2.5 min 40% ACN, 2.5--4 min 40% ACN, 4--14 min 40%--95% at a flow rate of 0.4 mL/min at 40 °C. This HPLC system was coupled to an Impact II QTOF (Bruker) mass spectrometer using Na-formiate as an internal calibration standard \[[@B24-jof-03-00009]\]. Carotenoids were detected in a positive ion mode with scanning range from 100--1200 *m*/*z*. Optical spectra were recorded online with a photodiode array detector 994 (Waters, Milford, CT, USA). Carotenoid standards for identification were generated in *E. coli* by the combination of different *crt* genes as previously described \[[@B25-jof-03-00009]\].

3. Results {#sec3-jof-03-00009}
==========

Although fungi are in general unable to synthesize zeaxanthin or other hydroxy-carotenoids, formation of the 3,3'-dihydroxy-β-carotene can be engineered into *X. dendrorhous* \[[@B12-jof-03-00009]\]. This potential was extended for the synthesis of other derivatives with up to six hydroxyl groups. As outlined in [Figure 1](#jof-03-00009-f001){ref-type="fig"}, this was achieved by a strategy involving the use of a β-carotene accumulating mutant of *X. dendrorhous*, its consecutive transformation with three microbial transgenes and finally the reduction of the 4- and 4'-keto groups. [Figure 2](#jof-03-00009-f002){ref-type="fig"} shows the HPLC analysis to identify some of the β-carotene-derived oxo compounds from the transgenic lines. Transformation with a bacterial 3-hydroxylase gene changed the PR1-104 from a β-carotene accumulator (trace A) to a transformant synthesizing zeaxanthin together with small amounts of the intermediate β-cryptoxanthin (trace B). In a second transformation step, with a bacterial 2-hydroxylase gene, the line PR1-104-ZG was obtained in which β-carotene was converted to nostoxanthin (trace C) as indicated by the nostoxanthin standard in trace D. Oxygenation of nostoxanthin was increased by a third transformation step with an algal 4-ketolase gene. In the resulting transformant PR1-104-ZGbkt, several carotenoids were detected. For base-line HPLC separation of these very polar oxo carotenoids, system I had to be changed to system II ([Figure 2](#jof-03-00009-f002){ref-type="fig"}, trace E). In addition to the expected nostoxanthin-derived keto carotenoids, other carotenoids such as β-carotene (peak 7) and its keto derivatives echinenone (peak 6) and canthaxanthin (peak 5) as well as 4-keto-zeaxanthin (peak 4) and nostoxanthin (peak 3) were generated and could be identified with standard carotenoids ([Figure 2](#jof-03-00009-f002){ref-type="fig"}, traces F and G). Compounds **1** and **2** of trace E are highly polar diketo and mono keto derivatives, respectively, as indicated by their optical absorbance spectra exhibiting a typical shape for keto carotenoids and an absorbance maximum of 475 or 468 nm ([Figure 3](#jof-03-00009-f003){ref-type="fig"}).

The carotenoid extract from transformant PR1-104-ZGbkt was reduced and separated by HPLC ([Figure 4](#jof-03-00009-f004){ref-type="fig"}A). New peaks 8 to 12 emerged, which were not present in the non-reduced sample. Peaks 10 to 12 could be identified by chromatography of standards as 4,4'-dihydroxy-β-carotene (trace C), 4-hydroxy-4'-keto-β-carotene (trace B) and 4-hydroxy-β-carotene (trace D). Peaks 8 and 9 exhibited similar spectra with absorbance maxima and shoulder values at 424, 450 and 477 nm ([Figure 3](#jof-03-00009-f003){ref-type="fig"}). Both compounds were obtained when isolated individual compounds from the non-reduced fraction were reduced. Isolated compound **1** changed into compound **8** and **2** into **9** ([Figure 4](#jof-03-00009-f004){ref-type="fig"}, right part). The absorbance spectra of the all-*trans* isomers 1, 2, 8 and 9 together with individual *cis* carotenoids indicated with same primed number are shown in [Figure 3](#jof-03-00009-f003){ref-type="fig"}.

Final identification of compounds **1**, **2**, **8** and **9** was performed using high resolution mass spectrometry ([Figure 5](#jof-03-00009-f005){ref-type="fig"}). Compound **1** showed a molecular mass of 628.3745 Da ([Table 2](#jof-03-00009-t002){ref-type="table"}) and fragments of M-17, M-17-17 and M-92 ([Figure 5](#jof-03-00009-f005){ref-type="fig"}A). This molecular mass identifies compound **1** as 4,4'-diketo-nostoxanthin. Its reduction product, compound **8**, with a molecular mass of 632.4077 Da ([Table 2](#jof-03-00009-t002){ref-type="table"}) is regarded as 4,4'-dihydroxy-nostoxanthin. Instead of the M-17 and M-17-17 fragments of compound **1**, the fragments M-18 and M-18-18 were present in its mass spectrum. ([Figure 5](#jof-03-00009-f005){ref-type="fig"}B). Therefore, compound **8** is regarded as 4,4'-dihydroxy-nostoxanthin. Compound **2** exhibits a fragmentation pattern in which the M-17-17 fragment of compound **1** is replaced by M-17-18 ([Figure 5](#jof-03-00009-f005){ref-type="fig"}C). It has a molecular mass of 614.3947 Da ([Table 2](#jof-03-00009-t002){ref-type="table"}). This identifies compound **2** as 4-keto-nostoxanthin. Upon its reduction, the molecular mass increased to 616.4102 Da ([Table 2](#jof-03-00009-t002){ref-type="table"}). The M-92 fragment is retained but instead of M-17, an M-18 fragment and instead of M-17-18, an M-18-18 fragment appears ([Figure 5](#jof-03-00009-f005){ref-type="fig"}D). These features of compound **9** correspond to 4-hydroxy-nostoxanthin. Common to the keto carotenoid **1** and **2** is a prominent peak at 147.12, which is much less pronounced in the reduced compounds **8** and **9**. The concentrations of these keto carotenoids in *X. dendrorhous* were determined as 37.4 ± 1.1 (µg/g dw) for 4,4'-diketo-nostoxanthin and 48.8 ± 1.4 (µg/g dw) for 4-keto-nostoxanthin. Their chemical reduction was almost complete ([Figure 4](#jof-03-00009-f004){ref-type="fig"}A), which implies similar concentrations for 4,4'-dihydroxy-nostoxanthin and 4-hydroxy-nostoxanthin, respectively.

4. Discussion {#sec4-jof-03-00009}
=============

Production of carotenoids by genetically engineered yeasts proved to be a promising alternative to chemical synthesis or extraction from plants \[[@B26-jof-03-00009]\]. The red yeast *X. dendrorhous* is the most versatile host with the highest carotenoid yield among fungi \[[@B5-jof-03-00009]\]. It is possible to construct and implement pathways to different carotenoid structures into this yeast. As an example, the synthesis to multi-oxygenated carotenoids was chosen in this publication ([Figure 1](#jof-03-00009-f001){ref-type="fig"}) to demonstrate the potential of *X. dendrorhous* as a production platform for complex carotenoid structures. This was possible by extension of the pathway from accumulating β-carotene. The step-by-step transformation resulted in intermediary lines accumulating zeaxanthin or nostoxanthin as major carotenoids ([Figure 2](#jof-03-00009-f002){ref-type="fig"}). Nostoxanthin is a carotenoid found in cyanobacteria \[[@B27-jof-03-00009]\] and was accumulated in recombinant *Escherichia coli* \[[@B14-jof-03-00009]\]. A final *X. dendrorhous* line PR1-104-ZGbkt transformed with three microbial genes produced 4-keto-nostoxanthin and 4,4'-diketo-nostoxanthin ([Figure 2](#jof-03-00009-f002){ref-type="fig"}). Both carotenoids are extremely rare in nature and have been identified before only from two bacteria *Brevundimonas* SD212 and *Rhizobium lupine* \[[@B28-jof-03-00009],[@B29-jof-03-00009]\]. By reduction of both keto carotenoids isolated from our line PR1-104-ZGbkt, the novel carotenoids 4-hydroxy-nostoxanthin and 4,4'-dihydroxy-nostoxanthin were obtained ([Figure 4](#jof-03-00009-f004){ref-type="fig"}). Some of the isolated oxo carotenoids separated into several geometrical isomers on the C30 column ([Figure 3](#jof-03-00009-f003){ref-type="fig"}). In each case, the all-*trans* isomer dominated. The isomers **1'** and **2'** showed a *cis* peak at 370 nm and **9'** at 330 nm. According to their height in relation to the dominating absorbance maximum, their position in front of the all-*trans* isomer on a C30 column and in comparison to astaxanthin for the keto derivatives \[[@B6-jof-03-00009]\] and to zeaxanthin for 4-hydroxy-nostoxanthin \[[@B30-jof-03-00009]\], these isomers are most likely 13-*cis*. In contrast, **1''** without a *cis* peak may be a 9-*cis* 4,4'-diketo-nostoxanthin isomer.

The keto carotenoids and their reduction products were identified by high resolution mass spectrometry ([Figure 5](#jof-03-00009-f005){ref-type="fig"}). For all of them, the correct molecular masses and the typical prominent fragments were obtained ([Table 2](#jof-03-00009-t002){ref-type="table"}). As indicated in the right part of [Figure 5](#jof-03-00009-f005){ref-type="fig"}A, fragment M-92 originates from an in chain elimination of a toluene unit and is an indication of the central polyene chain \[[@B31-jof-03-00009]\]. All analyzed carotenoids show the elimination of hydroxyl groups either as water (M-18) or as neutral loss of 17 Da. In addition, an intensified peak was found at 147.12 Da in the spectra of the mono and diketo derivaties ([Figure 5](#jof-03-00009-f005){ref-type="fig"}A,C). This is typical for a dehydrated 4-keto-β-ionone ring with cleavage of the C7,8 bond \[[@B31-jof-03-00009]\].

Our combined approach of mutant selection, genetic engineering and chemical modification is set as a general example of how novel carotenoids can be generated in *X. dendrorhous*. For the production of 4-keto-nostoxanthin and 4,4'-diketo-nostoxanthin, it is a proof of concept, which also indicates how to improve their yields in future studies. Judging from the relative low conversion of β -carotene to zeaxanthin ([Figure 2](#jof-03-00009-f002){ref-type="fig"}B) and complete conversion of zeaxanthin to nostoxanthin ([Figure 2](#jof-03-00009-f002){ref-type="fig"}C), the 3-hydroxylation step is regarded limiting in the formation of ketolated nostoxanthin. Formation of ketolated β-carotene derivatives echinenone and canthaxanthin demonstrate that the ketolation step is not limited ([Figure 2](#jof-03-00009-f002){ref-type="fig"}E). It has previously been shown that conversion rates of transgenic reactions in *X. dendrorhous* are dependent on the number of *trans* gene copies integrated into the genome \[[@B32-jof-03-00009]\]. Therefore, either transformation with a plasmid carrying two copies of the 3-hydroxylase gene *crtZ* as demonstrated by Pollmann et al. \[[@B12-jof-03-00009]\] or repeated transformation with the *crtZ* gene is a promising way to improve intermediate conversion to the end product. In addition, overall carotenoid synthesis can be enhanced up to 3-fold by improvement of precursor supply in combination with increased flux into the carotenoid pathway \[[@B12-jof-03-00009]\] and in combination with a high carotenoids producing *X. dendrorhous* mutant, a total increase of carotenoid formation of up to 90-fold can be achieved \[[@B7-jof-03-00009]\].
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![Pathway construction by genetic engineering of *Xanthophyllomyces dendrorhous* for the synthesis of multi-oxygenated β-carotene derivatives. Open arrows indicate chemical reduction. Novel carotenoid structures are boxed.](jof-03-00009-g001){#jof-03-00009-f001}

![HPLC separation of hydroxy and keto carotenoids from *Xanthophyllomyces dendrorhous* lines obtained by consecutive transformation with different *trans* genes. Traces **A**--**D** separated in HPLC system I, **E**--**H** in system II. Standards are shown in traces **D**, **F**--**H**. Abbreviations (and assignment of corresponding peaks): β-Car β-carotene (7), Zeax zeaxanthin, Cryp β-cryptoxanthin, Nostox nostoxanthin (3), Calox caloxanthin, Canth canthaxanthin (5), Ech echinenone (6), 4KZ 4-keto-zeaxanthin (4).](jof-03-00009-g002){#jof-03-00009-f002}

![Absorbance spectra of hydroxy-keto carotenoids before (compounds **1** and **2** with *cis* isomers **1', 1''** and **2'**) and after reduction (compounds **8** and **9** with *cis* isomer **9'**).](jof-03-00009-g003){#jof-03-00009-f003}

![HPLC separation of hydroxy carotenoids after reduction (**A**--**D**) and isolated peaks 1 and 2 from [Figure 2](#jof-03-00009-f002){ref-type="fig"} and their reduction products in system II. Standards are shown in traces **B**--**D**. Abbreviations (and assignment of corresponding peaks): β-Car, β-carotene; Ech, echinenone; 4-HO-4'-K-βcar, 4-hydroxy-4'-keto-β-carotene (11); 4,4'-diHO-βCar, 4,4'-dihydroxy-β-carotene (10); 4-HO-β-Car, 4-hydroxy-β-carotene (12).](jof-03-00009-g004){#jof-03-00009-f004}

![(**A**--**D**) MS-MS analysis of de-novo generated hydroxyl and keto-hydroxy β-carotene derivatives before and after reduction. The structures are indicated including the fragmentation pattern exemplified for 4-keto-nostoxanthin.](jof-03-00009-g005){#jof-03-00009-f005}

jof-03-00009-t001_Table 1

###### 

Genes and oligonucleotides for PCR amplification of the *Xanthophyllomyces dendrorhous*transformation plasmids.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Plasmid                                                           Primers
  ----------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------
  pPRcDNA1bkt830                                                    β-Carotene 4-ketolase gene *bkt* from *Haematococcus pluvialis* (D45881)

  [Primers]{.ul}: 5'-ATATGAATTCATGCACGTCGCATCGGCACT-3' (forward)\   
  5'-TATACTCGAGTCATGCCAAGGCAGGCACCAG-3' (reverse)                   

  pPR2TNH-crtG                                                      β-Carotene 2-hydroxylase gene *crtG* from *Brevundimonas* SD212 \[[@B16-jof-03-00009]\] (AB181388)

  [Primers]{.ul}: 5'-GGAATTCATGTTGAGGGATCTGCTCATC-3' (forward)\     
  5'-GCTCGAGTCACCGAAGAGGCGCTGAG-3' (reverse)                        

  pPR2TNo-crtZo                                                     β-Carotene 3-hydroxylase gene *crtZ* from *Brevundimonas* SD212 \[[@B21-jof-03-00009]\]), codon optimized (KX063854)

  [Sequence]{.ul}s: 5'-GAATTCATGGCTTGGCTCACCTGGA-3' (start)\        
  5'-ATCTTCTTCTTCTGGAGCT TGAGTCGAC-3' (end)                         
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

jof-03-00009-t002_Table 2

###### 

Overview of identified multi-oxygenated nostoxanthins using UPLC-ESI-HRMS.

  Compound   Trivial Name                  Sum Formula \[M\]^+^   Calculated *m/z*   Detected *m/z*   Mass Error \[Δppm\]
  ---------- ----------------------------- ---------------------- ------------------ ---------------- ---------------------
  **1**      4,4´-Diketo-nostoxanthin      C~40~H~52~O~6~         628.3758           628.3745         1.3
  **2**      4-Keto-nostoxanthin           C~40~H~54~O~5~         614.3966           614.3947         1.9
  **8**      4,4´-Dihydroxy-nostoxanthin   C~40~H~56~O~6~         632.4071           632.4077         0.6
  **9**      4-Hydroxy-nostoxanthin        C~40~H~56~O~5~         616.4122           616.4102         2.0
